Investors

Investor
Presentation

Most of the human population will require corrective lenses within their lifetime. As the natural lens deteriorates with age it will require more permanent, enduring solutions.

Ocumetics is in the process of developing advanced lens technologies that are designed to address issues of accommodation in the human eye, allowing near, intermediate, and distance range of vision, without lag, and as natural as the human eye.

Our goal is to enhance lives and change the way people see and experience the world around them!

Press Releases

stock info

stock quote

stock chart

financial

annual financial information

Year Ended December 31, 2022

Five Months Ended December 31, 2021

Year ended July 31, 2021

interim financial information

Year Ending December 31, 2023

2023 Q3 - September 30, 2023

2023 Q2 - June 30, 2023

2023 Q1 - March 31, 2023

Year Ending December 31, 2022

2022 Q3 - September 30, 2022

2022 Q2 - June 30, 2022

2022 Q1 - March 31, 2022

Five Months Ending December 31, 2021

Sign Up

We’ll keep you up to date on investor news and our clinical trials.